533 related articles for article (PubMed ID: 14517320)
1. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
Volonte D; Peoples AJ; Galbiati F
Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320
[TBL] [Abstract][Full Text] [Related]
2. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
[TBL] [Abstract][Full Text] [Related]
3. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
Smythe GM; Eby JC; Disatnik MH; Rando TA
J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
[TBL] [Abstract][Full Text] [Related]
4. Caveolae and caveolin-3 in muscular dystrophy.
Galbiati F; Razani B; Lisanti MP
Trends Mol Med; 2001 Oct; 7(10):435-41. PubMed ID: 11597517
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.
Galbiati F; Volonte D; Minetti C; Chu JB; Lisanti MP
J Biol Chem; 1999 Sep; 274(36):25632-41. PubMed ID: 10464299
[TBL] [Abstract][Full Text] [Related]
6. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.
Galbiati F; Volonte D; Chu JB; Li M; Fine SW; Fu M; Bermudez J; Pedemonte M; Weidenheim KM; Pestell RG; Minetti C; Lisanti MP
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9689-94. PubMed ID: 10931944
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.
Galbiati F; Engelman JA; Volonte D; Zhang XL; Minetti C; Li M; Hou H; Kneitz B; Edelmann W; Lisanti MP
J Biol Chem; 2001 Jun; 276(24):21425-33. PubMed ID: 11259414
[TBL] [Abstract][Full Text] [Related]
8. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.
Minetti C; Bado M; Broda P; Sotgia F; Bruno C; Galbiati F; Volonte D; Lucania G; Pavan A; Bonilla E; Lisanti MP; Cordone G
Am J Pathol; 2002 Jan; 160(1):265-70. PubMed ID: 11786420
[TBL] [Abstract][Full Text] [Related]
9. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation.
Merrick D; Stadler LK; Larner D; Smith J
Dis Model Mech; 2009; 2(7-8):374-88. PubMed ID: 19535499
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
[TBL] [Abstract][Full Text] [Related]
11. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3.
Galbiati F; Volonte D; Minetti C; Bregman DB; Lisanti MP
J Biol Chem; 2000 Dec; 275(48):37702-11. PubMed ID: 10973975
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-3 deficiency causes muscle degeneration in mice.
Hagiwara Y; Sasaoka T; Araishi K; Imamura M; Yorifuji H; Nonaka I; Ozawa E; Kikuchi T
Hum Mol Genet; 2000 Dec; 9(20):3047-54. PubMed ID: 11115849
[TBL] [Abstract][Full Text] [Related]
13. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy.
Repetto S; Bado M; Broda P; Lucania G; Masetti E; Sotgia F; Carbone I; Pavan A; Bonilla E; Cordone G; Lisanti MP; Minetti C
Biochem Biophys Res Commun; 1999 Aug; 261(3):547-50. PubMed ID: 10441463
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
[TBL] [Abstract][Full Text] [Related]
15. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells.
Couchoux H; Allard B; Legrand C; Jacquemond V; Berthier C
J Physiol; 2007 May; 580(Pt.3):745-54. PubMed ID: 17317753
[TBL] [Abstract][Full Text] [Related]
16. Zebrafish as a model for caveolin-associated muscle disease; caveolin-3 is required for myofibril organization and muscle cell patterning.
Nixon SJ; Wegner J; Ferguson C; Méry PF; Hancock JF; Currie PD; Key B; Westerfield M; Parton RG
Hum Mol Genet; 2005 Jul; 14(13):1727-43. PubMed ID: 15888488
[TBL] [Abstract][Full Text] [Related]
17. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
Hnasko R; Lisanti MP
Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
[TBL] [Abstract][Full Text] [Related]
18. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.
Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH
Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985
[TBL] [Abstract][Full Text] [Related]
19. Filopodia powered by class x myosin promote fusion of mammalian myoblasts.
Hammers DW; Hart CC; Matheny MK; Heimsath EG; Lee YI; Hammer JA; Cheney RE; Sweeney HL
Elife; 2021 Sep; 10():. PubMed ID: 34519272
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-3 helps build muscles.
Marx J
Science; 2001 Nov; 294(5548):1864. PubMed ID: 11729301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
